A national cancer clinical trials system for the 21st century: reinvigorating the NCI cooperative group program
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C.
National Academies Press
2010
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 Volltext |
Beschreibung: | Includes bibliographical references Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials "The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description |
Beschreibung: | 1 Online-Ressource (xviii, 295 p.) |
ISBN: | 0309151864 0309151872 1282787438 9780309151863 9780309151870 9781282787438 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043128247 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 151126s2010 |||| o||u| ||||||eng d | ||
020 | |a 0309151864 |9 0-309-15186-4 | ||
020 | |a 0309151872 |c electronic bk. |9 0-309-15187-2 | ||
020 | |a 1282787438 |9 1-282-78743-8 | ||
020 | |a 9780309151863 |9 978-0-309-15186-3 | ||
020 | |a 9780309151870 |c electronic bk. |9 978-0-309-15187-0 | ||
020 | |a 9781282787438 |9 978-1-282-78743-8 | ||
035 | |a (OCoLC)611632162 | ||
035 | |a (DE-599)BVBBV043128247 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 616.9940072 |2 22 | |
110 | 2 | |a Institute of Medicine (U.S.) |b Committee on Cancer Clinical Trials |e Verfasser |4 aut | |
245 | 1 | 0 | |a A national cancer clinical trials system for the 21st century |b reinvigorating the NCI cooperative group program |c Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services |
264 | 1 | |a Washington, D.C. |b National Academies Press |c 2010 | |
300 | |a 1 Online-Ressource (xviii, 295 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references | ||
500 | |a Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials | ||
500 | |a "The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description | ||
610 | 1 | 4 | |a NCI Cooperative Group Program (National Cancer Institute) |
650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
650 | 7 | |a Cancer / Treatment |2 fast | |
650 | 7 | |a Clinical trials |2 fast | |
650 | 4 | |a Clinical Trials as Topic / United States | |
650 | 4 | |a Organization and Administration / United States | |
650 | 4 | |a Neoplasms / therapy | |
650 | 4 | |a Medizin | |
650 | 4 | |a Clinical trials |z United States | |
650 | 4 | |a Cancer |x Treatment |z United States | |
651 | 4 | |a USA | |
710 | 2 | |a NCI Cooperative Group Program (National Cancer Institute) |e Sonstige |4 oth | |
710 | 2 | |a Institute of Medicine (U.S.) |b Board on Health Care Services |e Sonstige |4 oth | |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326 |x Aggregator |3 Volltext |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-028552438 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175564865536000 |
---|---|
any_adam_object | |
author_corporate | Institute of Medicine (U.S.) Committee on Cancer Clinical Trials |
author_corporate_role | aut |
author_facet | Institute of Medicine (U.S.) Committee on Cancer Clinical Trials |
author_sort | Institute of Medicine (U.S.) Committee on Cancer Clinical Trials |
building | Verbundindex |
bvnumber | BV043128247 |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)611632162 (DE-599)BVBBV043128247 |
dewey-full | 616.9940072 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.9940072 |
dewey-search | 616.9940072 |
dewey-sort | 3616.9940072 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03280nmm a2200577zc 4500</leader><controlfield tag="001">BV043128247</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309151864</subfield><subfield code="9">0-309-15186-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309151872</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-15187-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282787438</subfield><subfield code="9">1-282-78743-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309151863</subfield><subfield code="9">978-0-309-15186-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309151870</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-15187-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282787438</subfield><subfield code="9">978-1-282-78743-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)611632162</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043128247</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9940072</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on Cancer Clinical Trials</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A national cancer clinical trials system for the 21st century</subfield><subfield code="b">reinvigorating the NCI cooperative group program</subfield><subfield code="c">Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xviii, 295 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">NCI Cooperative Group Program (National Cancer Institute)</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Organization and Administration / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">NCI Cooperative Group Program (National Cancer Institute)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Board on Health Care Services</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028552438</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV043128247 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:18:18Z |
institution | BVB |
isbn | 0309151864 0309151872 1282787438 9780309151863 9780309151870 9781282787438 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028552438 |
oclc_num | 611632162 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 Online-Ressource (xviii, 295 p.) |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | National Academies Press |
record_format | marc |
spelling | Institute of Medicine (U.S.) Committee on Cancer Clinical Trials Verfasser aut A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services Washington, D.C. National Academies Press 2010 1 Online-Ressource (xviii, 295 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials "The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description NCI Cooperative Group Program (National Cancer Institute) MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Cancer / Treatment fast Clinical trials fast Clinical Trials as Topic / United States Organization and Administration / United States Neoplasms / therapy Medizin Clinical trials United States Cancer Treatment United States USA NCI Cooperative Group Program (National Cancer Institute) Sonstige oth Institute of Medicine (U.S.) Board on Health Care Services Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326 Aggregator Volltext |
spellingShingle | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program NCI Cooperative Group Program (National Cancer Institute) MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Cancer / Treatment fast Clinical trials fast Clinical Trials as Topic / United States Organization and Administration / United States Neoplasms / therapy Medizin Clinical trials United States Cancer Treatment United States |
title | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program |
title_auth | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program |
title_exact_search | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program |
title_full | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services |
title_fullStr | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services |
title_full_unstemmed | A national cancer clinical trials system for the 21st century reinvigorating the NCI cooperative group program Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services |
title_short | A national cancer clinical trials system for the 21st century |
title_sort | a national cancer clinical trials system for the 21st century reinvigorating the nci cooperative group program |
title_sub | reinvigorating the NCI cooperative group program |
topic | NCI Cooperative Group Program (National Cancer Institute) MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Cancer / Treatment fast Clinical trials fast Clinical Trials as Topic / United States Organization and Administration / United States Neoplasms / therapy Medizin Clinical trials United States Cancer Treatment United States |
topic_facet | NCI Cooperative Group Program (National Cancer Institute) MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Cancer / Treatment Clinical trials Clinical Trials as Topic / United States Organization and Administration / United States Neoplasms / therapy Medizin Clinical trials United States Cancer Treatment United States USA |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334326 |
work_keys_str_mv | AT instituteofmedicineuscommitteeoncancerclinicaltrials anationalcancerclinicaltrialssystemforthe21stcenturyreinvigoratingthencicooperativegroupprogram AT ncicooperativegroupprogramnationalcancerinstitute anationalcancerclinicaltrialssystemforthe21stcenturyreinvigoratingthencicooperativegroupprogram AT instituteofmedicineusboardonhealthcareservices anationalcancerclinicaltrialssystemforthe21stcenturyreinvigoratingthencicooperativegroupprogram |